What a SpaceX IPO could mean for Tesla shareholders, Pfizer pursuing next weight-loss drug in Chinese labs, more news to ...
Morgan Stanley analyst Terence Flynn raised the firm’s price target on Regeneron (REGN) to $768 from $767 and keeps an Equal Weight rating on the ...
JPMorgan lifts price target to $475 as Q4 AI revenue surges 74% to $6.5B with $73B backlog, but valuation concerns emerge at ...
Wall Street trading got off to a mixed start on Friday after both the Dow Jones and S&P 500 wrapped up the previous session ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback